COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is Mexico’s federal regulatory agency responsible for evaluating, approving, and monitoring all medical devices, pharmaceuticals, supplements, and health-related products sold in the Mexican market. Often called “Mexico’s FDA equivalent,” COFEPRIS operates under the Secretaría de Salud (Ministry of Health) and enforces the General Health Law (Ley General de Salud) through a system of sanitary registrations, import permits, and post-market surveillance.
Any healthcare company planning to sell medical devices, diagnostics, pharmaceuticals, or supplements in Mexico must obtain a COFEPRIS sanitary registration before the first unit can be imported or sold. There is no provisional market access, no grace period, and no exemption for products already approved by the FDA, CE, or other regulatory bodies.
This creates a critical path dependency for market entry: COFEPRIS registration is the single longest lead-time item in any Mexico go-to-market plan, typically requiring 6 to 18 months depending on product classification. Companies that treat it as an afterthought regularly lose 12+ months of revenue to avoidable delays.
The complexity is compounded by several factors that catch international companies off guard: documentation must be submitted in Spanish with certified translations, a legal representative (apoderado legal) physically located in Mexico is required, and certain product categories require in-country laboratory testing at COFEPRIS-approved facilities.
This hub brings together our complete library of COFEPRIS and Mexico regulatory content — from foundational explainers to detailed process guides and cost analyses. Whether you are evaluating Mexico as a new market or troubleshooting a stalled registration, you will find specific, actionable guidance based on our experience managing 350+ registrations across medical devices, diagnostics, pharmaceuticals, and supplements.
.jpeg)
